{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:39:05Z","timestamp":1791927545724,"version":"4.3.4"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.jaad.2006.05.009","type":"journal-article","created":{"date-parts":[[2006,8,13]],"date-time":"2006-08-13T07:06:09Z","timestamp":1155452769000},"page":"449-459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Rituximab: A monoclonal antibody to CD20 used in the treatment of pemphigus vulgaris"],"prefix":"10.1016","volume":"55","author":[{"given":"Abdul Kader","family":"El Tal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall R.","family":"Posner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Spigelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Razzaque","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2006.05.009_bib1","doi-asserted-by":"crossref","first-page":"396","DOI":"10.7326\/0003-4819-92-3-396","article-title":"Pemphigus: current concepts","volume":"92","author":"Ahmed","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2006.05.009_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0190-9622(79)80050-X","article-title":"Pemphigus and pemphigoid","volume":"1","author":"Lever","year":"1979","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.05.009_bib3","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1001\/archderm.1942.01500150014002","article-title":"Pemphigus: a clinical analysis and follow-up study of sixty-two patients","volume":"46","author":"Lever","year":"1942","journal-title":"Arch Dermatol Syphilol"},{"key":"10.1016\/j.jaad.2006.05.009_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archderm.1996.03890260105016","article-title":"The adjuvant therapy of pemphigus","volume":"132","author":"Bystryn","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.05.009_bib5","first-page":"375","article-title":"Corticosteroids: a review with emphasis on complications of prolonged systemic therapy","volume":"62","author":"Truhan","year":"1989","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jaad.2006.05.009_bib6","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0190-9622(85)70097-7","article-title":"Immunosuppressive agents for use in dermatology","volume":"12","author":"McDonald","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.05.009_bib7","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0190-9622(84)80193-0","article-title":"Cyclophosphamide","volume":"11","author":"Ahmed","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.05.009_bib8","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1517\/13543784.13.8.1019","article-title":"Treatment of autoimmune mucocutaneous blistering diseases with intravenous immunoglobulin therapy","volume":"13","author":"Ahmed","year":"2004","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jaad.2006.05.009_bib9","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1196\/annals.1361.118","article-title":"Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss","volume":"1051","author":"Sapir","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaad.2006.05.009_bib10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1146\/annurev.med.55.091902.104249","article-title":"Rituximab: expanding role in therapy for lymphomas and autoimmune diseases","volume":"55","author":"Rastetter","year":"2004","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jaad.2006.05.009_bib11","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1191\/0961203305lu2138oa","article-title":"Anti-B cell therapy (rituximab) in the treatment of autoimmune diseases","volume":"14","author":"Chambers","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.jaad.2006.05.009_bib12","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1067\/mjd.2002.126273","article-title":"Anti-CD20 chimeric monoclonal antibody (rituximab) for the treatment of recalcitrant, life-threatening pemphigus vulgaris with implications in the pathogenesis of the disorder","volume":"47","author":"Salopek","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.05.009_bib13","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1046\/j.1365-2230.2003.01283.x","article-title":"Treatment of resistant pemphigus vulgaris with an anti-CD20 monoclonal antibody (rituximab)","volume":"28","author":"Cooper","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2006.05.009_bib14","article-title":"Anti-CD20 monoclonal antibody (rituximab) in the treatment of autoimmune diseases. Successful result in refractory Pemphigus vulgaris: report of a case","volume":"88","author":"Virgolini","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.jaad.2006.05.009_bib15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/archderm.140.1.91","article-title":"Treatment of refractory pemphigus vulgaris with rituximab (anti-CD20 monoclonal antibody)","volume":"140","author":"Dupuy","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.05.009_bib16","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.jaad.2003.08.021","article-title":"Long-term complete remission of severe pemphigus vulgaris with monoclonal anti-CD20 antibody therapy and immunophenotype correlations","volume":"50","author":"Espana","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.05.009_bib17","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jaad.2004.06.007","article-title":"Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab)","volume":"51","author":"Morrison","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.05.009_bib18","first-page":"185","article-title":"Successful rituximab treatment of severe pemphigus vulgaris resistant to multiple immunosuppressants","volume":"85","author":"Wenzel","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2006.05.009_bib19","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2133.2005.06740.x","article-title":"Long-standing remission of recalcitrant juvenile pemphigus vulgaris after adjuvant therapy with rituximab","volume":"153","author":"Schmidt","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.05.009_bib20","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2133.2005.06651.x","article-title":"Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus","volume":"153","author":"Arin","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.05.009_bib21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1525-1470.2005.00118.x","article-title":"Successful treatment of refractory childhood pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab)","volume":"22","author":"Kong","year":"2005","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2006.05.009_bib22","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1046\/j.1365-2133.2003.05209_10.x","article-title":"Treatment of pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab)","volume":"148","author":"Herrmann","year":"2003","journal-title":"Br J Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2006.05.009_bib23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000246938","article-title":"Correlation of subclasses of IgG with disease activity in pemphigus vulgaris","volume":"189","author":"Bhol","year":"1994","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2006.05.009_bib24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1006\/clim.2002.5259","article-title":"Isotypes and antigenic profiles of pemphigus foliaceus and pemphigus vulgaris","volume":"105","author":"Hacker","year":"2002","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaad.2006.05.009_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jdermsci.2004.03.011","article-title":"Conformational epitope mapping of antibodies against desmoglein 3 in experimental murine pemphigus","volume":"35","author":"Anzai","year":"2004","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2006.05.009_bib26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.clim.2005.03.005","article-title":"Role of intramolecular epitope spreading in pemphigus vulgaris","volume":"116","author":"Salvato","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaad.2006.05.009_bib27","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V83.2.435.435","article-title":"Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20","volume":"83","author":"Reff","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2006.05.009_bib28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000082104","article-title":"Treatment of SLE with anti-CD20 monoclonal antibody","volume":"8","author":"Looney","year":"2005","journal-title":"Curr Dir Autoimmun"},{"issue":"Suppl 12","key":"10.1016\/j.jaad.2006.05.009_bib29","first-page":"79","article-title":"The use of rituximab in the treatment of malignant and non malignant plasma cell disorders","volume":"27","author":"Treon","year":"2000","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jaad.2006.05.009_bib30","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.coph.2004.03.006","article-title":"Anti B cell therapy (rituximab) in the treatment of autoimmune diseases","volume":"4","author":"Kazkaz","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jaad.2006.05.009_bib31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/rheumatology\/40.2.205","article-title":"Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes","volume":"40","author":"Edwards","year":"2001","journal-title":"Rheumatology (Oxf)"},{"key":"10.1016\/j.jaad.2006.05.009_bib32","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1182\/blood-2002-02-0392","article-title":"Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura","volume":"99","author":"Stasi","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2006.05.009_bib33","first-page":"1273","article-title":"Rituximab in the treatment of refractory autoimmune cytopenias in adults","volume":"90","author":"Narat","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.jaad.2006.05.009_bib34","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1046\/j.1365-2141.2001.0115_1cr-4.x","article-title":"Rituximab in a case of cold agglutinin disease","volume":"115","author":"Zaja","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaad.2006.05.009_bib35","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1002\/art.10345","article-title":"Rituximab for the treatment of type II mixed cryoglobulinemia","volume":"46","author":"Zaja","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2006.05.009_bib36","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1212\/WNL.52.8.1701","article-title":"IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using rituximab","volume":"52","author":"Levine","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jaad.2006.05.009_bib37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.coph.2005.01.010","article-title":"Myasthenia gravis: emerging new therapy options","volume":"5","author":"Sieb","year":"2005","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jaad.2006.05.009_bib38","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1002\/1529-0131(200112)44:12<2836::AID-ART471>3.0.CO;2-W","article-title":"Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy","volume":"44","author":"Specks","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2006.05.009_bib39","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/art.20849","article-title":"Rituximab in the treatment of dermatomyositis: an open-label pilot study","volume":"52","author":"Levine","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2006.05.009_bib40","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/art.21260","article-title":"Rituximab treatment in patients with primary Sjogren's syndrome: an open-label phase II study","volume":"52","author":"Pijpe","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2006.05.009_bib41","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1399-0012.2005.00334.x","article-title":"Anti-CD20 monoclonal antibody (rituximab) for life-threatening hemolytic-uremic syndrome","volume":"19","author":"Yassa","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jaad.2006.05.009_bib42","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/art.20718","article-title":"Induction of remission by B lymphocyte depletion in eleven patients with refractory anti-neutrophil cytoplasmic antibody associated vasculitis","volume":"52","author":"Keogh","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2006.05.009_bib43","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/ard.61.10.922","article-title":"Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab)","volume":"61","author":"Arzoo","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2006.05.009_bib44","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.biopha.2004.04.006","article-title":"Rituximab in autoimmune diseases","volume":"58","author":"Virgolini","year":"2004","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jaad.2006.05.009_bib45","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1182\/blood.V94.7.2217.419k02_2217_2224","article-title":"Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody (rituximab, IDEC-C2B8)","volume":"94","author":"Winkler","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2006.05.009_bib46","first-page":"224","article-title":"Anti-B- cell-directed immunotherapy (rituximab) in the treatment of refractory pemphigus\u2014an update","volume":"15","author":"Arin","year":"2005","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2006.05.009_bib47","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/annonc\/mdf350","article-title":"Stevens-Johnson syndrome after treatment with rituximab","volume":"13","author":"Lowndes","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaad.2006.05.009_bib48","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/(SICI)1096-8652(199912)62:4<247::AID-AJH9>3.0.CO;2-T","article-title":"Tumor lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: high-grade non-Hodgkins lymphoma and chronic lymphocytic leukaemia","volume":"62","author":"Yang","year":"1999","journal-title":"Ann J Haematol"},{"key":"10.1016\/j.jaad.2006.05.009_bib49","first-page":"894","article-title":"Fatal varicella-zoster infection following rituximab and chemotherapy treatment in a patient with follicular lymphoma","volume":"85","author":"Bermudez","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.jaad.2006.05.009_bib50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1086\/345746","article-title":"Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment","volume":"36","author":"Quartier","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2006.05.009_bib51","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10156-005-0385-Z","article-title":"HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb","volume":"11","author":"Sarrecchia","year":"2005","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jaad.2006.05.009_bib52","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/1042819021000055110","article-title":"Severe autoimmune hemolytic anemia following rituximab therapy in a patient with a lymphoproliferative disorder","volume":"44","author":"Jourdan","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jaad.2006.05.009_bib53","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ajh.20413","article-title":"Rituximab-induced acute liver failure after an allogeneic transplantation for chronic myeloid leukemia","volume":"80","author":"Qazilbash","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaad.2006.05.009_bib54","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaad.2004.12.048","article-title":"Progression of classic Kaposi's sarcoma with rituximab","volume":"53","author":"Clifford","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.05.009_bib55","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood-2004-08-3198","article-title":"B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis","volume":"106","author":"Dunleavy","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2006.05.009_bib56","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/archderm.139.8.1051","article-title":"Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases","volume":"139","author":"Ahmed","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.05.009_bib57","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(01)06573-4","article-title":"Treatment of childhood autoimmune hemolytic anemia with rituximab","volume":"358","author":"Quartier","year":"2001","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2006.05.009_bib58","doi-asserted-by":"crossref","first-page":"A103","DOI":"10.1055\/s-2001-17506","article-title":"[Intravenous immunoglobulins in the prevention of infection in children with hematologic-oncologic diseases.]","volume":"213","author":"Lehrnbecher","year":"2001","journal-title":"Klin Padiatr"},{"key":"10.1016\/j.jaad.2006.05.009_bib59","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/bbmt.2002.v8.pm11939601","article-title":"Intravenous immunoglobulin: appropriate indications and uses in hematopoietic stem cell transplantation","volume":"8","author":"Sokos","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaad.2006.05.009_bib60","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJM199009133231103","article-title":"Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation","volume":"323","author":"Sullivan","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2006.05.009_bib61","doi-asserted-by":"crossref","first-page":"7359","DOI":"10.1038\/sj.onc.1206939","article-title":"Rituximab (monoclonal anti-CD20 antibody): mechanism of action and resistance","volume":"22","author":"Smith","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.jaad.2006.05.009_bib62","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/art.10541","article-title":"An open study on B lymphocyte depletion in systemic lupus erythematosus","volume":"46","author":"Leandro","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2006.05.009_bib63","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1365-2133.2003.05580.x","article-title":"Rapid response of treatment-resistant pemphigus foliaceus to the anti-CD20 antibody rituximab","volume":"149","author":"Goebeler","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.05.009_bib64","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1182\/blood.V69.2.597.597","article-title":"Hematologic engraftment and immune reconstitution posttransplantation with anti-B1 purged autologous bone marrow","volume":"69","author":"Anderson","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2006.05.009_bib65","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1083\/jcb.121.5.1121","article-title":"Transfection of the CD20 cell surface molecule into ectopic cell types generates a Ca2R conductance found constitutively in B-lymphocytes","volume":"121","author":"Bubien","year":"1993","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jaad.2006.05.009_bib66","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/art.10947","article-title":"Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy","volume":"48","author":"Silverman","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"Suppl 2","key":"10.1016\/j.jaad.2006.05.009_bib67","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/sonc.2002.30156","article-title":"Rituximab: mechanism of action and resistance","volume":"29","author":"Maloney","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jaad.2006.05.009_bib68","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1067\/mjd.2001.116339","article-title":"Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatments","volume":"45","author":"Ahmed","year":"2001","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962206012898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962206012898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:02:55Z","timestamp":1759269775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962206012898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0190962206012898"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2006.05.009","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rituximab: A monoclonal antibody to CD20 used in the treatment of pemphigus vulgaris","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2006.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}